Sep 14, 2022 / 07:30PM GMT
Jason Russell - Morgan Stanley - MD
Great. Good afternoon. Before we jump in, Zandy, I will read our candy dandy research disclosure. So for important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative. Great. My name is Jason Russell. I am Managing Director with the Morgan Stanley Healthcare Banking team. Delighted to be joined by Zandy Forbes, Dr. Zandy Forbes to be very clear. And really excited to have Meira at our conference. There's a lot to talk about. You -- 6 clinical programs, I believe across various TAs, Phase 3 trial enrolling, big partnership, manufacturing, wholly owned manufacturing site and then Riboswitch which is really exciting. So I want to cover it all. Let's try and jump in.
Maybe just start with some high-level perspectives on MeiraGTx, a brief overview of the company, your vision. Let's start there.
Alexandria Forbes - MeiraGTx Holdings plc - CEO, President & Director
Yes. So
MeiraGTx Holdings PLC at Morgan Stanley Global Healthcare Conference Transcript
Sep 15, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers